Brown Brothers Harriman & Co’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-126
| Closed | -$3.74K | – | 1290 |
|
|
2023
Q4 | $3.74K | Hold |
126
| – | – | ﹤0.01% | 1019 |
|
|
2023
Q3 | $2K | Hold |
126
| – | – | ﹤0.01% | 1106 |
|
|
2023
Q2 | $2.38K | Hold |
126
| – | – | ﹤0.01% | 1120 |
|
|
2023
Q1 | $484 | Hold |
126
| – | – | ﹤0.01% | 1214 |
|
|
2022
Q4 | $625 | Hold |
126
| – | – | ﹤0.01% | 1205 |
|
|
2022
Q3 | $1K | Hold |
126
| – | – | ﹤0.01% | 1494 |
|
|
2022
Q2 | $1K | Sell |
126
-142
| -53% | -$617 | ﹤0.01% | 1289 |
|
|
2022
Q1 | $1K | Sell |
268
-22,500
| -99% | -$125K | ﹤0.01% | 1251 |
|
|
2021
Q4 | $169 | Hold |
22,768
| – | – | ﹤0.01% | 508 |
|
|
2021
Q3 | $129 | Hold |
22,768
| – | – | ﹤0.01% | 524 |
|
|
2021
Q2 | $150 | Hold |
22,768
| – | – | ﹤0.01% | 492 |
|
|
2021
Q1 | $184 | Sell |
22,768
-2,500
| -10% | -$20.4K | ﹤0.01% | 434 |
|
|
2020
Q4 | $163K | Buy |
+25,268
| New | +$147K | ﹤0.01% | 474 |
|
|
2020
Q2 | – | Sell |
-275
| Closed | -$1K | – | 1234 |
|
|
2020
Q1 | $1K | Buy |
+275
| New | +$1.2K | ﹤0.01% | 1062 |
|
|
2019
Q3 | – | Sell |
-134
| Closed | – | – | 1308 |
|
|
2019
Q2 | $0 | Buy |
134
+36
| +37% | +$85 | ﹤0.01% | 1255 |
|
|
2019
Q1 | $0 | Buy |
+98
| New | +$424 | ﹤0.01% | 1134 |
|
|
2018
Q4 | – | Sell |
-141
| Closed | -$1K | – | 1008 |
|
|
2018
Q3 | $1K | Buy |
+141
| New | +$1.35K | ﹤0.01% | 801 |
|
|
2014
Q2 | – | Sell |
-22
| Closed | – | – | 826 |
|
|
2014
Q1 | $0 | Buy |
+22
| New | +$347 | ﹤0.01% | 825 |
|
Other funds holding IMGN
Brown Brothers Harriman & Co's IMGN Position: Q1 2024 in Review
Brown Brothers Harriman & Co sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 126 shares — an estimated $3.74K sold.
Brown Brothers Harriman & Co first reported a position in IMGN in Q1 2014 and held it in 18 quarters. The position peaked at $163K in Q4 2020. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Brown Brothers Harriman & Co reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 126 Immunogen Inc shares in Q1 2024, an estimated $3.74K.
- Brown Brothers Harriman & Co first reported a position in Immunogen Inc in Q1 2014 and held it in 18 quarters.
- Brown Brothers Harriman & Co's Immunogen Inc position peaked at $163K in Q4 2020.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Brown Brothers Harriman & Co's 13F filing for Q1 2024, filed 10 May 2024.